corneal abrasion. Chloramphenicol ointment was prescribed, and the patient was advised to tape her left eyelid shut at night. Four days later, corneal exposure with a persistent corneal abrasion was still evident. Surgical tarsorrhaphy was refused; however, the patient consented to tarsorrhaphy with Indermil. The tarsorrhaphy lasted 7 days, during which the corneal abrasion healed. Function of the left facial muscles was restored during this period, and the exposure keratopathy resolved.
Case 3. A 40-year-old man was seen in the eye casualty with a 4-day history of facial nerve palsy secondary to herpes zoster infection. Corneal exposure with a central abrasion was evident. There was 5 mm of lagophthalmos. He was prescribed chloramphenicol ointment and advised to tape his eyelids shut at night. He subsequently developed a skin allergy to the tape and discontinued its use. A subsequent examination found a persistent central corneal abrasion. The patient refused surgical tarsorrhaphy but was agreeable to lateral tarsorrhaphy with Indermil. The first tarsorrhaphy lasted 6 days but his lower eyelid function remained poor, and worsening of the exposure keratitis occurred over the next 5 days. Glue tarsorrhaphy with Indermil was performed on 2 other occasions, each lasting 7 days. At the end of the third application, the corneal defect had healed and eyelid function recovered satisfactorily.
Comment. Exposure keratitis is a complication of facial nerve palsy. Without treatment, this may lead to corneal ulceration with severe visual loss from scarring and infection. In mild cases, exposure keratopathy can be managed conservatively with copious lubricants and eyelid taping, but in severely affected corneas, eyelid closure may be required to maintain corneal integrity. Surgical tarsorrhaphy and botulinum toxin-induced ptosis are 2 well-recognized methods of providing corneal protection. Both are effective but have their disadvantages.
Surgical tarsorraphy may be divided into suture tarsorrhaphy over bolsters (for short-term use) and reversible permanent eyelid adhesion tarsorrhaphy (for longer-term use). The former is commonly accepted as the gold standard for temporary eyelid closure. However, both forms of surgical tarsorrhaphy are time consuming, and there may be a risk of permanent scarring to the eyelids from surgery. In addition, patients often refuse surgical tarsorrhaphy for cosmetic reasons. On the other hand, botulinum toxin may not be available universally because of constraints of cost and expertise. Moreover, the induced ptosis is variable in its onset and duration, and there are risks associated with the injection.
An alternative approach is to perform glue-assisted tarsorrhaphy. Indermil is a tissue adhesive (N-butyl-2-cyanoacrylate monomer) that is widely used in surgery for the closure of skin wounds and internal wounds without the need for suturing.
1 The use of Indermil has also been described in obstetric and gynecologic procedures, otolaryngologic procedures, hand surgery, and plastic and reconstructive surgery. The use of cyanoacrylate glue has been described previously in the management of corneal epithelial defects 2 and other ocular problems.
3 However, there has been little documentation to date on the successful use of licensed medical preparations of tissue glue for tarsorrhaphy.
Indermil-assisted tarsorrhaphy lasts for about a week and can easily be repeated when necessary. With regard to safety, a previous case series has suggested that there is no longterm morbidity from superglue contact with the eye. 4 The technique is not a replacement for surgical tarsorrhaphy; however, it may be considered as an alternative in certain situations. First, the technique can be used to provide short-term corneal protection prior to recovery of facial nerve palsy. Second, it may serve as a temporary measure for exposure keratopathy while awaiting more definitive treatment. Third, it is of value in patients who refuse surgical intervention. 
Li Wern Voon, FRCS(Edin

Corticosteroids, Central Serous Chorioretinopathy, and Neurocysticercosis
Report of a Case. A 38-year-old Mexican American man sought care because of decreased vision in both eyes for the past 9 months, although it had worsened in the past 6 weeks. He also complained of neck stiffness and headaches. He was a butcher, had lived in Mexico until age 22 years, and had visited there 2 years previously. His visual acuity was 20/70 OD and 20/100 OS. Fundus examination showed serous retinal detachments, and VogtKoyanagi-Harada syndrome was diagnosed. He was treated with 100 mg of oral prednisone per day. His visual acuity improved slightly to 20/50 OD and 20/100 OS but then deteriorated to 20/200 OD and 20/60 OS. His serous detachments did not resolve. During the next 10 months, he was treated with 1 injection of 40 mg of sub-Tenon triamcinolone acetonide in the right eye, 25 mg of oral methotrexate weekly, 60 mg of oral prednisone daily, and 1 injection of 4 mg of intraocular triamcinolone in the right eye. His visual acuity and serous retinal detachments did not improve.
On May 15, 2002, the patient's visual acuity was 20/70 OD and 20/50 OS, and he had multiple serous retinal detachments with fibrin in each eye ( Figure 1A ). Fluorescein angiography showed multiple areas of leakage ( Figure 1B The diagnosis of central serous chorioretinopathy (CSC) was considered, and the oral prednisone was gradually reduced.
On June 13, 2002, the patient's visual acuity was 20/60 OU. The patient stated that he had fainted the day before and was not feeling well. He was receiving 5 mg of prednisone daily and 25 mg of methotrexate weekly. The prednisone was increased to 10 mg daily, and he was scheduled to see a neurologist.
On June 17, 2002, the patient sought care at the emergency department with the worst headache he had ever had. He reported loss of consciousness and a possible seizure. He received phenytoin sodium and dexamethasone intravenously. Magnetic resonance imaging showed multilocular cystic lesions in the lateral ventricles bilaterally, with gross dilation of the lateral and third ventricles consistent with obstructive hydrocephalus (Figure 2) . Neurocysticercosis was diagnosed and treated with 400 mg of albendazole twice daily for 8 days, phenytoin, and a ventriculoperitoneal shunt. Subsequently, his visual acuity improved to 20/40 OD and 20/30 OS, and his serous retinal detachments resolved. Phenytoin remained his sole treatment.
Comment. This case was a confusing one of a Mexican American man with serous retinal detachments, neck stiffness, and headaches mimicking Vogt-Koyanagi-Harada syndrome, although there was no inflammation in the vitreous. We now believe he had CSC causing visual symptoms and neurocysticercosis causing neck stiffness and headache. We do not know if the increased intracranial pressure and its stress with possible concomitant glucocorticoid production played a role in his severe CSC. Glucocorticoid use has been associated with subretinal fibrin in CSC.
1
The oral prednisone and periocular and intraocular triamcinolone did not improve the CSC and ultimately worsened it. The correct diagnosis with tapering of corticosteroids caused resolution of the serous fluid but worsened the symptoms of hydrocephalus from the neurocysticercosis.
This case shows that it is important to make the distinction between CSC and inflammatory causes of serous retinal detachments because corticosteroids will make CSC worse.
2,3 Another learning point is that serous fluid due to VogtKoyanagi-Harada syndrome should promptly resolve after treatment 
